MedPath

Rye Bread Trial; Antioxidative and Cholesterol Lowering Effects

Phase 2
Completed
Conditions
Hypercholesterol
Interventions
Dietary Supplement: Rye-2008
Registration Number
NCT01084226
Lead Sponsor
University of Helsinki
Brief Summary

The purpose of this study is to investigate the antioxidative effects of alkylresorcinols (AR), originating from the rye fiber, on serum LDL particles and the use of AR or it's metabolites as biomarkers for rye fiber intake and the effect of additional plants sterols, incorporated in the rye bread, on serum total and LDL cholesterol concentration.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • healthy
  • volunteer
  • hemoglobin above 125 mmol/L in females, above 135 mmol/L in males
Exclusion Criteria
  • taking drugs affecting plasma lipids or gastrointestinal track
  • severe illness
  • use of antibiotics within 3 months before entering the study
  • use of vitamin pills or fish oil 1 month before entering the study
  • pregnancy or lactating

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
controlRye-2008No added plant sterol in the identical-looking rye bread
SterolRye-2008Additional plant sterols incorporated in the rye bread
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Folkhälsan Research Center

🇫🇮

Helsinki, Finland

© Copyright 2025. All Rights Reserved by MedPath